External validation of the Baseline Recurrence Risk in Cellulitis (BRRISC) score and the added impact of acute clinical response: a prospective cohort study
Elizabeth L A Cross, Gail N Hayward, Martin J Llewelyn, A Sarah Walker · 2025
Read External validation of the Baseline Recurrence Risk in Cellulitis (BRRISC) score and the added impact of acute clinical response: a prospective cohort study by Elizabeth L A Cross, Gail N Hayward, Martin J Llewelyn, A Sarah Walker (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12751828.txt.
Description
Elizabeth Cross and co-authors test a risk score for skin infection in a 2025 study. Cellulitis is a painful bacterial infection, here in the lower leg, that brings many patients to hospital. The BRRISC score aims to predict, at first visit, whose infection will come back and need hospital care again.
The team followed 202 adults treated in hospital and tracked how each patient responded over the first three days. The score predicted hospital returns fairly well in this new group, better than in its first test. It did worse at predicting any return, including mild ones treated in the community. One early sign, skin blistering on day two or three, may sharpen the score. The authors say response signs alone did not predict milder returns.
Catalog record
| CREATOR | Elizabeth L A Cross, Gail N Hayward, Martin J Llewelyn, A Sarah Walker |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |